** Shares of Vita Life Sciences VLS.AX rise as much as
22.8% to A$0.7 - their biggest intraday pct. gain since
September 2018
** Company says for the first half of FY20, it expects EBIT
to be around A$3.7 mln to A$4.1 mln ($2.64 mln to $2.93 mln) and
sales of about A$21.5 mln to A22.0 mln, both higher than the
previous corresponding period urn:newsml:reuters.com:*:nFWN2ET16X
** Stock at its highest since Jan. 20
** About 49,000 shares change hands, compared with the
30-day average of about 33,000 shares
** Stock down 14.9% this year, as of last close
($1 = 1.4010 Australian dollars)
(Reporting by Soumyajit Saha in Bengaluru)
((Soumyajit.Saha@thomsonreuters.com;))